CA Patent

CA2813358A1 — Fast crystallizing crystalline-amorphous ink compositions and methods for making the same

Assigned to Xerox Corp · Expires 2013-10-26 · 13y expired

What this patent protects

A phase change ink composition comprising an amorphous component, and a crystalline material, which are suitable for ink jet printing, including printing on coated paper substrates. In particular, the functional group(s) present in the amorphous component differ from the function…

USPTO Abstract

A phase change ink composition comprising an amorphous component, and a crystalline material, which are suitable for ink jet printing, including printing on coated paper substrates. In particular, the functional group(s) present in the amorphous component differ from the functional group(s) present in the crystalline component. In particular, the phase change inks compositions solidify fast and are suitable for high speed printing.

Drugs covered by this patent

Patent Metadata

Patent number
CA2813358A1
Jurisdiction
CA
Classification
—
Expires
2013-10-26
Drug substance claim
No
Drug product claim
No
Assignee
Xerox Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.